In addition, overexpression of ADAM12 enhanced the growth and progression of human CRC cells, and knockdown of ADAM12 showed potent anti-tumor activity in our in vivo mouse xenograft model. The gene discussed is ADAM12; the disease is colorectal carcinoma.